Elan Corporation, plc - Financial and Strategic Analysis Review

Elan Corporation, plc - Financial and Strategic Analysis Review

Elan Corporation, plc - Financial and Strategic Analysis Review

Summary

Elan Corporation, plc (Elan) is an Irish based biotechnology company, incepted in 1969. The company is focused on the research, development, manufacturing and marketing of advanced therapies in neurology, autoimmune diseases and severe pain. The company operates its business through its two units namely: Biopharmaceuticals and Elan Drug Technologies (EDT). The company is headquartered at Dublin, Ireland.

Global Markets Direct’s Elan Corporation, plc - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Elan Corporation, plc. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

- Provides key company information for business intelligence needs.
- The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

- A quick “one-stop-shop” to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

Table Of Contents

Table Of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Business Description 4
Major Products and Services 5
History 6
SWOT Analysis 7
SWOT Analysis - Overview 7
Elan Corporation, plc - Strengths 7
Elan Corporation, plc - Strengths - Diversified Product Portfolio 7
Elan Corporation, plc - Strengths - Focused Research and Development 7
Elan Corporation, plc - Strengths - Strong Financial Performance 7
Elan Corporation, plc - Strengths - Innovative NanoCrystal Technology 7
Elan Corporation, plc - Weaknesses 7
Elan Corporation, plc - Weaknesses - Deteriorating Performance of Maxipine 7
Elan Corporation, plc - Weaknesses - Maxipime/Azactam Assets Impairments 7
Elan Corporation, plc - Weaknesses - Poor Liquidity Conditions 8
Elan Corporation, plc - Opportunities 8
Elan Corporation, plc - Opportunities - Growing Incidence in Neurological Diseases 8
Elan Corporation, plc - Opportunities - Pipeline Products 8
Elan Corporation, plc - Opportunities - Approval of TYSABRI 8
Elan Corporation, plc - Opportunities - Emerging Markets 8
Elan Corporation, plc - Opportunities - Changing Demographics 8
Elan Corporation, plc - Threats 9
Elan Corporation, plc - Threats - Intensifying Competition 9
Elan Corporation, plc - Threats - Tightening of the FDA’s Regulatory Oversight 9
Elan Corporation, plc - Threats - Protection of Intellectual Property 9
Elan Corporation, plc - Threats - Impact of the Financial Crisis 9
Elan Corporation, plc - Threats - Increased Pricing Control 9
Key Competitors 10
Key Employees 10
Key Employee Biographies 11
Company Statement 12
Locations And Subsidiaries 13
Locations And Subsidiaries - Head Office 13
Locations And Subsidiaries - Other Locations & Subsidiaries 13
Financial Ratios 14
Financial Ratios - Capital Market Ratios 14
Financial Ratios - Annual Ratios 14
Financial Ratios - Interim Ratios 15
Financial Ratios - Ratio Charts 16
Appendix 17
Methodology 17
Ratio Definitions 17
About Global Markets Direct 20
Contact Us 20
Disclaimer 20


List of Tables

Elan Corporation, plc, Key Facts 4
Major Products and Services 5
Elan Corporation, plc, History 6
Elan Corporation, plc, Key Employees 10
Elan Corporation, plc, Key Employee Biographies 11
Elan Corporation, plc, Subsidiaries 13
Elan Corporation, plc, Ratios based on current share price 14
Elan Corporation, plc, Annual Ratios 14
Elan Corporation, plc, Interim Ratios 15
Currency Codes 17
Capital Market Ratios 17
Equity Ratios 18
Profitability Ratios 18
Cost Ratios 18
Liquidity Ratios 19
Leverage Ratios 19
Efficiency Ratios 19


List of Figures

Elan Corporation, plc, Ratio Charts 16